In an increasingly competitive landscape, pharmaceutical companies are finding creative ways to protect their patents. Most of the time, patents are the only things that protect a company from direct competition. If a drug is successful but still protected under a patent, other companies prepare their chemical synthesis manufacturing capabilities to be able to take […]
Tag: patent
Categories
Drug Approvals: Value-based Contracting
Value-based contracting helps hold Big Pharma accountable. If the drug shows a lack of clinical effectiveness and/or results in unreported side effects, the manufacture owes the plan sponsor two-thirds of the drug’s cost. Rishi Manchanda, the Chief Medical Officer (CMO) of The Wonderful Company, believes that the sequel to the triple aim is the quadruple […]
Categories
Drug Approvals: Biosimilar Drugs
Biosimilar drugs are identical copies of a product that has an expired patent. They are expected to increase competition and reduce drug prices. Europe, Canada, Japan, and Australia have sold dozens of biosimilar drugs for ten years. In the US, prices are expected to drop by 35%. In addition, $80 billion in sales will lose […]
Categories
Drug Approvals
Big Pharma is a dynamic and complex industry. Just a few of the stakeholders include researchers, drug companies, pharmacies, governmental agencies, health plans, doctors, and patients. Agencies such as the Food and Drug Administration (FDA), National Institutes of Health (NIH), Department of Health, and the Drug Enforcement Agency (DEA) have much influence on the pharmaceutical […]
Categories
Big Pharma Corruption: Placebos
Placebos are commonly viewed as fraud among the general public. Some news stories have said that some drugs that were sold as prescriptions were just milk and sugar. Although it is wrong to sell placebos in place of real drugs, placebos have a great deal of importance in pharmaceutical research. Placebos can make a control […]
The sneaky relationship between researchers and drug companies taint the trials and therefore put the patient in danger. Borison and Diamond, two psychiatrists from the Medical College of Georgia, are in jail because of endangering the safety of multiple patients by tainting trials of over twenty drugs in order to receive hundreds of thousands of […]
Over the past five years, debates about designer drugs have been growing. This new sector’s main focus is to genetically alter drugs so that they are custom for the individual patient. Although in theory this sounds like a health-improving technology, the failure of the multiple companies to agree on a destination and move forward is […]
Categories
Big Pharma Corruption
Big Pharma, the name we collectively attach to all of the drug companies, has been under scrutiny for the past few decades. The government, healthcare institutions, and drug companies collaborate together to supposedly provide us with the finest drugs for our consumption to maintain or improve our health. Peter Coy puts it perfectly, Big Pharma […]